Skip to content
HowShorted

Oruka Therapeutics, Inc. short interest in 2019

In 2019, Oruka Therapeutics, Inc.'s disclosed short interest ran from 2.64% of shares outstanding on 15 Jan 2019 to 0.35% on 31 Dec 2019, a change of -2.29 percentage points. The year's high was 14.46% on 15 May 2019 and its low 0.25% on 31 Oct 2019, averaging 2.46% across 15 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.52 days on 31 Jan 2019. Full history: Oruka Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Oruka Therapeutics, Inc. in 2019

2019 in figures

Start of year
2.64% (15 Jan 2019)
End of year
0.35% (31 Dec 2019)
Change
-2.29 pp
High
14.46% (15 May 2019)
Low
0.25% (31 Oct 2019)
Average
2.46%
Highest days to cover
5.52 (31 Jan 2019)
SEC filings marked
11

Every report in 2019

Oruka Therapeutics, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 20192.64%2.52
31 Jan 20192.61%5.52
15 Feb 20192.99%2.39
28 Feb 20193.44%1.00results (8-K), 10-K filed, results (8-K)
15 Mar 20193.00%1.00
29 Mar 20193.21%1.00
15 May 201914.46%1.0010-Q filed, results (8-K)
31 Jul 20190.88%1.00results (8-K), results (8-K)
15 Aug 20190.98%1.0010-Q filed, results (8-K)
30 Aug 20190.58%1.00
30 Sep 20190.58%1.00
31 Oct 20190.25%1.00
15 Nov 20190.36%1.0010-Q filed, results (8-K)
13 Dec 20190.55%1.00
31 Dec 20190.35%1.00

See also: Oruka Therapeutics, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.